Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The two companies are expanding their long-standing relationship.
January 8, 2026
By: Patrick Lavery
Veeva Systems and BioMarin Pharmaceutical have announced a partnership that the two companies say will build upon their long-standing relationship. The long-term enterprise agreement will leverage, and provide strategic input into, Veeva’s software, data, services, and consulting products.
On BioMarin’s end, the strategic partnership will help the company increase speed, agility, and operational efficiency, optimizing healthcare professional and patient experiences.
“This strategic partnership marks an important next step in our digital evolution,” said Alexander Hardy, President and Chief Executive Officer of BioMarin. “We are excited by the opportunity to combine our scientific capabilities with Veeva’s technological leadership that we believe will enable us to bring our transformative medicines more quickly to patients around the world.”
“Our partnership with BioMarin has always been guided by a shared set of values, including product excellence, value realization, and customer success,” said Veeva CEO Peter Gassner. “Building on this foundation, I look forward to how we can further support BioMarin as they advance important new medicines and reach even more patients around the world.”
Veeva’s Vault CRM, part of a suite of deep applications and agentic AI intended to drive more effective commercial execution, has drawn the attention of numerous top companies. The latest to commit to using its services is Novo Nordisk.
In 2025, Roche, Bristol Myers Squibb, Gilead Sciences, and Merck also committed to the customer relationship management platform.
Meanwhile, in the last week of 2025, BioMarin announced a pending $4.8 billion acquisition of Amicus Therapeutics. This followed the completion of a $270 million purchase of Inozyme Pharma in July 2025.
“BioMarin’s scale of operations, including our global commercial footprint and industry-leading, in-house manufacturing capabilities make the combination of these companies an exceptional strategic fit,” Hardy said of the Amicus deal.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
